Singapore Clinical Nutrition Market Report 2023 to 2030

Singapore Clinical Nutrition Market Analysis

$ 3999

The Singapore Clinical Nutrition Market was valued at $36.8 Mn in 2023 and is projected to grow at a CAGR of 5.94% from 2023 to 2023, to $55.1 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as iX Biopharma, NTUC Health, Baxter, Abbott Nutrition, Pfizer Inc, Nestle, Baxter International Inc. among others.

ID: IN10SGPH569 CATEGORY: Pharmaceuticals GEOGRAPHY: Singapore AUTHOR: Mahima Reddy

Buy Now

Singapore Clinical Nutrition Market Executive Summary

The Singapore Clinical Nutrition Market is at around $36.8 Mn in 2023 and is projected to reach $55.1 Mn in 2030, exhibiting a CAGR of 5.94% during the forecast period 2023-2030.

Clinical malnutrition refers to a condition that can be treated with clinical intervention by using specialized nutrients that are considered proper medications rather than as supplements. Clinical nutrition products are useful in maintaining the patient's health and enable the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. The clinical nutrition sector is undergoing a transformation fuelled by progress in medical research and technology. Key trends such as innovative formulations, personalized nutrition solutions, and the use of bioactive ingredients are emerging. Manufacturers are dedicating resources to R&D to produce products that not only fulfil fundamental nutritional requirements but also provide added health advantages. This emphasis on innovation is fostering competition among industry participants, resulting in a constant flow of new products and therapies tailored to various patient demographics.

Clinical nutritionists or registered dietitians work in hospitals, clinics, and other healthcare facilities to, assess patients' nutritional status, develop personalized nutrition plans, provide nutrition education, manage nutrition-related diseases like diabetes, malnutrition etc, support optimal health and well-being. Some areas of focus in clinical nutrition include, critical care nutrition, paediatric nutrition, oncology nutrition, gastrointestinal nutrition, sports nutrition etc.

The prevalence of chronic conditions like diabetes, cardiovascular diseases, and cancer is on the rise in Singapore. In 2020, the prevalence of diabetes among adults was 8.6%, and the age-standardized prevalence of hypertension was 24.9%. The major drivers of Clinical Nutrition industry in Singapore are, increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients.

The industry is primarily dominated by players such as iX Biopharma, NTUC Health, Baxter, Abbott Nutrition, Pfizer Inc, Nestle, Baxter International Inc. among others.

Singapore Clinical Nutrition Market Report 2023 to 2030

Market Dynamics

Market Drivers

Growing Aging Population: Singapore has a rapidly aging population, with the proportion of residents aged 65 and above expected to increase from 15.2% in 2021 to 23.8% by 2030. This growing geriatric population has higher nutritional needs, driving the demand for clinical nutrition products.

Rising Prevalence of Chronic Diseases: The prevalence of chronic conditions like diabetes, cardiovascular diseases, and cancer is on the rise in Singapore. In 2020, the prevalence of diabetes among adults was 8.6%, and the age-standardized prevalence of hypertension was 24.9%. The need for clinical nutrition to manage these diseases is a key market driver.

Increasing Health Consciousness: Singaporeans are becoming more health-conscious, with a growing focus on maintaining a nutritionally balanced diet. According to a survey, 77% of Singaporeans consider nutrition and diet as important factors for their overall health. This heightened awareness is contributing to the expansion of the clinical nutrition market.

Market Restraints

High Cost of Specialized Products: The high cost of specialized clinical nutrition products can be a barrier to their adoption, especially for lower-income individuals. This can limit the accessibility of these products to a significant portion of the population.

Limited Availability in Certain Areas: While Singapore has a well-developed healthcare system, there may be limited availability of clinical nutrition products in certain areas or neighbourhoods. This can hinder the reach and accessibility of these products.

Lack of Healthcare Professional Awareness: Some healthcare professionals may not be fully aware of the latest advancements and benefits of clinical nutrition. This lack of knowledge can lead to limited prescription and recommendation of these products to patients.

Regulatory Landscape and Reimbursement Scenario

Clinical nutrition regulation and reimbursement in Singapore are primarily overseen by the Health Sciences Authority (HSA), operating under the Ministry of Health (MOH). The HSA classifies clinical nutrition products as either medicinal products or health supplements, with medicinal products undergoing a more rigorous approval process through the Therapeutic Products Branch. Health supplements follow a notification scheme and must comply with specific safety, quality, and labeling guidelines.

The Agri-Food and Veterinary Authority (AVA) also plays a role in regulating food-based nutritional products. Reimbursement is integrated into Singapore's healthcare financing system, which includes MediSave (a national medical savings scheme), MediShield Life (basic health insurance), MediFund (a safety net for those who cannot afford medical bills), and Integrated Shield Plans (private insurance offering additional coverage).

Coverage for clinical nutrition interventions varies depending on whether they are part of inpatient care, outpatient treatment, or home care, with hospital-based support more likely to be covered. Recent developments include an increased focus on evidence-based nutrition therapy, emphasis on preventive health, efforts to harmonize regulations with international standards, and ongoing refinement of healthcare financing policies to balance accessibility with cost containment. Singapore's approach aims to ensure access to necessary clinical nutrition support while maintaining high safety and efficacy standards, with the regulatory and reimbursement landscape continually evolving to meet changing healthcare needs.

Competitive Landscape

Key Players

Here are some of the major key players in the Singapore Clinical Nutrition Market:

iX Biopharma
BioLife Sciences
NTUC Health
Abbott Nutrition
Pfizer Inc.
Amway
Nestle
Baxter International Inc.
Otsuka Holdings Co., Ltd.
Mead Johnson & Company, LLC

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Singapore Clinical Nutrition Market Segmentation

By Product

Oral Clinical Nutrition
Parenteral Nutrition
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solutions
Trace Elements
Vitamins & Minerals
Enteral Feeding Formulas
Standard Formula
Disease-specific Formulas
Others

By Application

Alzheimer’s Disease
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others

By Sales Channel

Retail Sales Channels
Online Sales Channels
Institutional Sales Channels
Others

End Users

Geriatric
Adults
Paediatric

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.